Agilent’s Postnatal Assay Gets European IVDR Class C Certification
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Andy Lundin | Apr 15, 2024 | Womens Health |
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read MorePosted by Chris Wolski | Apr 11, 2024 | Lab Management |
XiFin has published the reimbursement rates for key pathology and molecular tests, giving key data for benchmarking.
Read MorePosted by Andy Lundin | Apr 9, 2024 | Compliance |
ADLM released the results of a survey the organization conducted to determine how the FDA’s proposed LDT rule would impact patient care.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Diagnostic Technologies |
The new diagnostic tool combines optofluidics and nanopore technology to create a lab-on-a-chip diagnostic system.
Read MorePosted by Andy Lundin | Apr 8, 2024 | Prostate |
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read More